BioAscent to showcase Compound Cloud at ‘Open Access to Drug Discovery’
Dr Phil Jones will be attending the ‘Open Access to Drug Discovery’ event at the University of Cambridge on the 23rd November.
The showcasing event will provide insight to the vast array of open access opportunities available to researchers who are wishing to start or progress on a drug discovery pathway.
BioAscent will be presenting on Compound Cloud, and the access to a compound library over 125,000 lead-like and drug-like compounds.
Other speakers from AstraZeneca, ChEMBL, EU OPENSCREEN, GSK, J&Ji and UCB will also be presenting on a range of topics including chemical databases and tools, compound screening services and antibody development opportunities which are available.
For more information, click here.